USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PANTHERA BIOPHARMA, LLC
Address:
PANTHERA BIOPHARMA, LLC
99-193 AIEA HEIGHTS DR, STE 136
AIEA, HI 96701
Phone:
N/A
URL:
N/A
EIN:
120531070
DUNS:
620852769
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,559,955.00 2
SBIR Phase II $2,695,398.00 1

Award List:

Inhibitors of Anthrax Lethal Factor Metalloproteinase

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$2,695,398.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Anthrax Lethal Factor (LF) is a metalloproteinase introduced into the cells of mammalian hosts during infection by the bacterium Bacillus anthracis. LF disrupts intracellular signaling pathways mediated by the MAPKKs, r esulting in cell toxicity, sepsis,… More

Development of a Recombinant Subunit Ebola Vaccine

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$959,998.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Ebola and Marburg viruses, the only members of the family Filoviridae, cause hemorrhagic fevers which are lethal in up to 90% of human cases. No vaccine or antiviral therapy currently exists to prevent or treat Filoviru s infection. Due to their exceptional… More

Discovery of Broad Spectrum Dengue Virus Proteinase Inhibitors

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$599,957.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Over half of the world population is at risk for infection by dengue virus, a mosquito borne member of the Flavivirus family that consists of four distinct serotypes. Approximately 50 to 100 million infections occur ann ually resulting in an estimated 500,000… More